Oral SERDs in ER+/HER2- metastatic breast cancer, an analysis of ESR1 wild type/mutant subgroups
27/11/2023
Benefits with nimotuzumab plus gemcitabine in K-Ras wild-type pancreatic cancer
11/12/2023